Neradecast
Neradecast represents a more recent therapeutic advance beyond pirfenidone and nintedanib in the IPF treatment timeline. Neradecast was the first new IPF therapy to receive FDA approval in over a decade. Neradecast received FDA approval as…
1 sources - 3 claims
Neradecast represents a more recent therapeutic advance beyond pirfenidone and nintedanib in the IPF treatment timeline. Neradecast was the first new IPF therapy to receive FDA approval in over a decade. Neradecast received FDA approval as an IPF treatment.